Signaling Pathways in Cancer Symposium 2013

Understanding Signaling Pathways in Cancer

Friday, November 8, 2013

Speakers

Michael Yaffe
Koch Institute at MIT
Opening Remarks


View Video

Robert A. Weinberg

Robert Weinberg
Whitehead Institute and Koch Institute at MIT
Signals Triggering the EMT and Cancer Stem Cell Formation


View Video

Stephen Baylin headshot

Stephen Baylin
John Hopkins University School of Medicine
Cell signaling and clues to the origin of the cancer epigenome


View Video

Giulio Draetta headshot

Giulio Draetta
The University of Texas MD Anderson Cancer Center
Understanding Context-Dependent Relevance of Potential Cancer Drug Targets


View Video

J. Wade Harper

J. Wade Harper
Harvard Medical School
Proteomic exploration of ubiquitin-like protein

No video available

Steven Gygi
Harvard Medical School
Measuring cellular signaling using MS-based proteomics

View Video

Giulio Draetta headshot

Philip Cohen
University of Dundee
Will drugs that target components of the MyD88-dependent signaling network be useful for the treatment of Diffuse Large B cell Lympoma?

View Video

Yossi Shiloh
Tel Aviv University Sackler School of Medicine
ATM: regulating the cellular response to genotoxic stress, and more


View Video

Robert T. Abraham headshot Robert T. Abraham
Pfizer Worldwide Research and Development
Zeroing in on an oncogenic driver: The rapid evolution of targeted therapies for Anaplastic Lymphoma Kinase-positive lung cancer

No video available
John Blenis headshot

John Blenis
Harvard Medical School
Tumor Cell Signaling and Metabolism


View Video

William Sellers headshot

William Sellers
Novartis Institutes for BioMedical Research
Towards robust and systematic translational systems for cancer therapeutic development

View Video

Neal Rosen headshot

Neal Rosen
Memorial Sloan-Kettering Cancer Center
Oncoprotein-activated feedback--biologic and therapeutic implications

View Video